Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate Efficacy Under Different Breakfast Conditions in ADHD
NCT00428792Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2007
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Novartis. Started Apr 2007; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00428792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00428792.